Status:
WITHDRAWN
COVID Vaccine Immunity in Kidney Transplant Recipients
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
ViraCor Laboratories
Conditions:
End Stage Renal Disease
Kidney Transplant; Complications
Eligibility:
All Genders
18+ years
Brief Summary
50 end-stage renal disease (ESRD) patients whom have had at least 2 doses of messenger ribonucleic acid (mRNA) vaccine, and undergoing transplantation at the University of Alabama at Birmingham (UAB) ...
Detailed Description
50 ESRD patients on peritoneal dialysis or hemodialysis or not on immunosuppression, no prior transplant, no known history of COVID infection, whom have had at least 2 doses of mRNA vaccine, and under...
Eligibility Criteria
Inclusion
- End Stage Renal Disease patients on peritoneal dialysis or hemodialysis or not on immunosuppression
- no prior transplant
- no known history of COVID infection
- had at least 2 doses of mRNA COVID vaccine
- undergoing transplantation at the University of Alabama at Birmingham
- multi-organ transplant allowed
Exclusion
- active COVID infection
- participant is not vaccinated against COVID
Key Trial Info
Start Date :
November 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05387343
Start Date
November 1 2022
End Date
November 1 2024
Last Update
October 28 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.